Drug Discovered To Treat Diabetic Neuropathy!
Diabetic neuropathy is a condition in which the kidney cells are damaged due to high blood glucose levels. It is one of the major causes of end stage kidney disease in the USA.
A collaborative study conducted by the researchers from the National Institute of Health (NIH), University of California, Mayo Clinic and San Diego School of Medicine has revealed that an anti inflammatory and anti fibrotic drug named pirfenidone is effective in treating diabetic patients with kidney disease.
According to Kumar Sharma, the lead author of this study, a precise dose of pirfenidone not only halted the damage of the kidney cells but also improved its functioning in the patients tested.
The study was conducted on 77 randomly selected diabetic neuropathy patients. They were divided into 3 groups. One group was given a low dose of pirfenidone (1200 mg), the second group was given a high dose (2400mg) and the third group served as control.
After one year, low dose group showed significant improvement in kidney functioning whereas the high dose group did not show any change.
Before it can be made available to the common man, the researchers are planning to conduct a clinical study on a large group.